Aperio Clinical Outcomes to Present at LaunchBio on “Begin With the End in Mind: Preparing for First-in-Human Clinical Trials”

April 9, 2019

Panel Presentation Will Feature Leading Industry Experts from Aperio Clinical Outcomes, Nuventra Pharma Sciences, SpringWorks Therapeutics and G1 Therapeutics 

Aperio Clinical Outcomes, a clinical research organization headquartered in Morrisville, NC, will present a panel presentation titled “Begin With the End in Mind: Preparing for First-in-Human Clinical Trials” at LaunchBio, Inc. on Thursday, May 2, 2019.

The presentation will help educate and guide the vibrant, early stage life science community located in the greater Research Triangle Park region, as they prepare to advance their molecules from preclinical development into first-in-human clinical trials. The panel will allow them to hear first-hand from some of the area’s top life science experts who have navigated this journey before. Topics will include:

• Assembling your team of experts
• Planning your regulatory strategy
• Preparing for your first clinical trial
• Developing your protocol synopsis
• Operationalizing your protocol

The panel is scheduled to take place from 4:30 – 5:30 pm at the Chesterfield Building in downtown Durham and will include a Q&A time with the panelists and ample networking opportunities afterward in the main room. Suzanne Kincaid, Chief Operating Officer with Aperio Clinical Outcomes, will moderate the panel. Panelists will include:

Brian D. Furmanski, PhD
Senior Director, Clinical Pharmacology & Pharmacokinetics
Nuventra Pharma Sciences, Inc.

Todd Shearer, PhD
Senior Director, Clinical Pharmacology
SpringWorks Therapeutics

Patrick Roberts, PharmD, PhD
Senior Director of Translational Medicine
G1 Therapeutics

To learn more or to register to attend LaunchBio, click here.